🇺🇸 FDA
Patent

US 11801218

Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine

granted A61KA61K2039/5256A61K2039/541

Quick answer

US patent 11801218 (Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine) held by The Board of Regents of the University of Texas System expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/5256, A61K2039/541, A61K39/12, A61K47/26